Hypertrophic cardiomyopathy (HCM) is a heterogeneous albeit treatable cardiac disease of
variable severity, with the potential for heart failure, atrial fibrillation and arrhythmic sudden …

Atrial fibrillation (AF) is common among patients with hypertrophic cardiomyopathy (HCM)
with a prevalence> 25%. AF in HCM is associated with a high risk of stroke and can be a …

Abstract Background and Aims Although extreme cardiac adaptions mirroring phenotypes of
cardiomyopathy have been observed in endurance athletes, adaptions to high levels of …

Background: Left ventricular maximum wall thickness (LVMWT) is an important biomarker of
left ventricular hypertrophy and provides diagnostic and prognostic information in …

Objective To contemporaneously reappraise the incidence-rate, prevalence, and natural
history of hypertrophic cardiomyopathy (HCM) in Olmsted County, Minnesota, from 1984 to …

Aims This study aims to determine the familial incidence of dilated (DCM) and hypertrophic
cardiomyopathy (HCM) in first‐degree, second‐degree, and third‐degree relatives of …

Background Little evidence is available on the disease expression in relatives of index
patients with hypertrophic cardiomyopathy (HCM). This information has important …

Inherited cardiomyopathies are genetic diseases that can lead to heart failure and sudden
cardiac death. These conditions tend to run in families, following an autosomal dominant …

Hypertrophic cardiomyopathy (HCM) is a common myocardial disease defined by increased
left ventricular wall thickness unexplained by loading conditions. It is frequently caused by …

Background Hypertrophic cardiomyopathy (HCM) is a leading cause of sudden cardiac
death. Current diagnosis emphasizes the detection of left ventricular hypertrophy (LVH) …